Back to Home
Free CE/CMEVideo

Live Tumor Board: Squamous Cell Carcinoma of the Head & Neck - Post-CRT Decisions in the Locally Advanced Setting

Release Date

March 30, 2026

Expiration Date

March 31, 2027

Credits

1.5 CME, NCPD

Specialties

General Oncology, Head & Neck Cancer+7 more

Activity Overview

This educational activity is an archive of the live presentation held on February 19, 2026.

For more information about this educational activity, the faculty, and disclosures, please click here.

Target Audience

This educational activity is directed toward medical oncologists, radiation oncologists, head & neck surgery/ENT, speech-language pathologists, nurse practitioners, physician assistants, nurses, pharmacists, and other health care practitioners involved in the treatment and management of locally advanced head and neck squamous cell carcinoma (LA-HNSCC).

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Describe the current role of post-CRT surveillance in patients with LA-HNSCC
  • Apply risk-stratified strategies to determine appropriate post-CRT management for patients with LA-HNSCC
  • Implement coordinated multidisciplinary care plans to mitigate and manage toxicities related to CRT in patients with HNSCC
  • Identify potentially eligible patients for ongoing clinical trials evaluating novel post-CRT treatment approaches
Live Tumor Board: Squamous Cell Carcinoma of the Head & Neck - Post-CRT Decisions in the Locally Advanced Setting

GET STARTED WITH THIS PROGRAM:

Register now to gain access to this program.

Create AccountAlready Registered? Login Here

Accreditation/Credit Designation

Physicians’ Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 1.5 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from AstraZeneca Pharmaceuticals.

Follow Us on Social Media!

Related Content

Course

Live Tumor Board: Squamous Cell Carcinoma of the Head & Neck - Post-CRT Decisions in the Locally Advanced Setting

Create Account